John Fowler, CEO of Mbody AI, shares insights on the evolution of robotics, the company's strategic approach to market expansion, and the lessons learned from the cannabis industry that shape their current growth strategy in autonomous robotics.Mbody AI: https://mbody.ai/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, David Halabu, CEO of Z Squared, shares his journey from finance and trading to pioneering AI infrastructure. Discover how his diverse background influences the company's innovative approach to repurposing cryptocurrency mining hardware for AI data centers and the strategic considerations behind site selection and development.Z Squared Inc: https://www.zsquaredinc.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, B. Scott Swann, CEO of ROC (Rank One Computing), shares insights from his 18-year career in biometric and identity technologies, his transition from the FBI to industry, and how AI is transforming security and identity verification in both government and private sectors.Rank One Computing: https://roc.ai/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, James Sapirstein, CEO of Cocrystal Pharma, shares insights into antiviral drug development, the company's innovative platform, and the future of infectious disease treatments. Discover how their unique approach aims to tackle viruses like norovirus, influenza, and rhinovirus, and what it takes to bring these solutions from lab to patient.Cocrystal Pharma Website: https://www.cocrystalpharma.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Will Tjernlund speaks with Dr. Bill Williams, President and CEO of BriaCell Therapeutics, a clinical-stage immuno-oncology company trading under the ticker BCTX.Dr. Williams discusses his transition from academia to the biotechnology industry, his role in advancing the blockbuster drug Jakafi, and why he personally invested millions of dollars in BriaCell alongside Chairman Jamieson Bondarenko.The conversation explores BriaCell’s lead candidate, Bria-IMT, an investigational immunotherapy being evaluated in late-stage metastatic breast cancer patients who have exhausted other treatment options. Dr. Williams explains how BriaCell genetically modifies cancer cells to stimulate a targeted immune response and discusses the company’s ongoing Phase 3 program.They also cover BriaCell’s personalized, off-the-shelf Bria-OTS platform, early clinical observations, the company’s expansion into prostate, lung, ovarian, and other cancers, and the potential commercialization paths available if its clinical programs are successful.Learn more about BriaCell Therapeutics and its pipeline at the company’s website.Ticker: BCTXThis conversation is for informational purposes only and should not be considered investment or medical advice.BriaCell Website: https://briacell.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Dr. Lior Shaltiel shares his journey from academia to biotech entrepreneurship, focusing on the innovative exosome technology developed by NerExone. Discover how this breakthrough could revolutionize treatments for central nervous system injuries and the strategic steps behind bringing biotech innovations to market.NurExone Biologic: https://nurexone.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, John Celenza, CEO of Cizzle Brands, shares insights into building a successful health-focused CPG company, the importance of brand differentiation, and strategic growth through manufacturing assets and public markets.Cizzle Brands: https://www.cizzlebrands.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This week, we sit down with Alessandro Petruzzi and Giordano Morichi, cofounders of Terra Innovatum (NASDAQ: NKLR), a nuclear energy technology company developing micro-modular reactors designed to deliver safe, reliable, and scalable power. They discuss the company’s innovative microreactor technology, its safety features, potential applications, and the role it could play in advancing energy independence. The conversation also explores the future of nuclear power, including the possibility of deploying microreactors in urban environments.Terra Innovatum Website: https://www.terrainnovatum.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

Joaquin Martin, CEO of Nomadar, shares insights on integrating technology with sports, real estate, and entertainment. Discover how innovative strategies are shaping the future of sports tourism, athlete performance, and multi-purpose event centers.NOMADAR WEBSITE: https://nomadar.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this interview, biotech CEO Eric Poma discusses the groundbreaking science behind Calidi Biotherapeutics oncolytic virus platform, its potential to revolutionize cancer treatment, and the company's development roadmap. Gain insights into innovative cancer therapies, clinical trial strategies, and future prospects.Calidi Biotherapeutics: https://www.calidibio.com/Nano Cap Podcast: https://www.nanocappod.com/DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.